Authors:
DEMETER LM
DAQUILA R
WEISLOW O
LORENZO E
ERICE A
FITZGIBBON J
SHAFER R
RICHMAN D
HOWARD TM
ZHAO YQ
FISHER E
HUANG D
MAYERS D
SYLVESTER S
ARENS M
SANNERUD K
RASHEED S
JOHNSON V
KURITZKES D
REICHELDERFER P
JAPOUR A
Citation: Lm. Demeter et al., INTERLABORATORY CONCORDANCE OF DNA-SEQUENCE ANALYSIS TO DETECT REVERSE-TRANSCRIPTASE MUTATIONS IN HIV-1 PROVIRAL DNA, Journal of virological methods, 75(1), 1998, pp. 93-104
Authors:
BADLEY AD
DOCKRELL DH
ALGECIRAS A
ZIESMER S
LANDAY A
LEDERMAN MM
CONNICK E
KESSLER H
KURITZKES D
LYNCH DH
ROCHE P
YAGITA H
PAYA CV
Citation: Ad. Badley et al., IN-VIVO ANALYSIS OF FAS FASL INTERACTIONS IN HIV-INFECTED PATIENTS/, The Journal of clinical investigation, 102(1), 1998, pp. 79-87
Authors:
SCHOOLEY RT
RAMIREZRONDA C
LANGE JMA
COOPER DA
LAVELLE J
LEFKOWITZ L
MOORE M
LARDER BA
STCLAIR M
MULDER JW
MCKINNIS R
PENNINGTON KN
HARRIGAN PR
KINGHORN I
STEEL H
ROONEY JF
RAY MG
KURITZKES D
RIVERAVASQUEZ C
SANTANA J
VANLEEUWEN R
BOUCHER C
REISS P
VEENSTRA J
KEET R
PIERCE P
HAAS D
BARNES B
LOEWENTHAL M
DARCYEVANS C
KEMP S
KOHLI A
MYERS R
YEO J
EMERY S
ROMERO C
ANDREWS J
HANSON C
SHORTINO D
PATTISHALL K
BARRY D
Citation: Rt. Schooley et al., VIROLOGICAL AND IMMUNOLOGICAL BENEFITS OF INITIAL COMBINATION THERAPYWITH ZIDOVUDINE AND ZALCITABINE OR DIDANOSINE COMPARED WITH ZIDOVUDINE MONOTHERAPY, The Journal of infectious diseases, 173(6), 1996, pp. 1354-1366
Authors:
CAVERT W
COOMBS RW
GRIMES J
KURITZKES D
JOHNSON V
KAPPES J
STEIN D
BEATTY C
ERICE A
WINTERS M
KATZENSTEIN D
JOHNSON E
ROJO E
MIRABILE M
ELBEIK T
TSIATIS B
COREY L
Citation: W. Cavert et al., THERAPEUTIC SIGNIFICANCE OF SWITCHING TO DIDANOSINE (DDI) OR ADDING DDI IN SUBJECTS WITH ZIDOVUIDINE-RESISTANT HIV-1, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 41-41